Robertet makes the aroma and flavour ingredients, natural extracts and fragrance compounds that go into perfumes, cosmetics, food and beverages, and it sells them to the big consumer brands on long supply contracts. The moat is in the formulation work: once a fragrance or flavour is locked into a product, customers rarely switch, and a 59.5% gross margin and 16.6% ROE say the pricing power is real. Revenue is down 0.5%, so the growth story has to come from mix, natural-ingredient demand and the next product cycle rather than volume. At 15.5x forward earnings against 17.4x trailing, the market is pricing in an earnings recovery, and with a 17.0% operating margin and a 1.6bn EUR market cap, the case rests on whether that margin holds while top-line growth turns positive again. Worth a deeper look to test that margin durability and the order book before any view on the multiple.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:52 CEST | ACCE price target | €851 | first publication | €776 |
| 22 Oct 2026, 13:04 CEST | Rating | Overvalued | first publication | €770 |
| 22 Oct 2026, 13:04 CEST | Fair value | €639 | first publication | €770 |
Answered from Robertet SA fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| RBT.PA Robertet SA | €780.00 | €639 | 22% above | 17.5x | 16.6% | 72 | 47 |
| OLN Olin Corporation Common Stock | $15.66 | $44 | 65% below | - | -10.6% | 22 | 26 |
| 4061.T Denka Company Limited | ¥2988.50 | - | - | 16.0x | 2.6% | 51 | 56 |
| HUN Huntsman Corporation Common Stock | $8.80 | - | - | - | -3.8% | 22 | 41 |
| KEMIRA.HE Kemira Oyj | €15.22 | €18 | 17% below | 15.7x | 9.5% | 52 | 41 |
| REX REX American Resources Corporation | $39.83 | $23 | 75% above | 10.9x | 19.6% | 76 | 66 |
| RDX.AX Redox Limited | A$3.50 | A$3 | 36% above | 20.6x | 16.6% | 64 | 65 |
Where RBT.PA ranks against its sector peers on each metric.